| Ashley Biegler, CRNA | |
|
1046 6th Ave Sw, Albany, OR 97321-1916 | |
| (541) 812-4000 | |
| Not Available |
| Full Name | Ashley Biegler |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 5 Years |
| Location | 1046 6th Ave Sw, Albany, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902367527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 201902594CRNA (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Regional Medical Center | Corvallis, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany General Hospital | 9931097987 | 162 |
| Good Samaritan Hospital Corvallis | 1557270725 | 339 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20031111000297 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Good Samaritan Hospital Corvallis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453134 PECOS PAC ID: 1557270725 Enrollment ID: O20031125000163 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Samaritan North Lincoln Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306897491 PECOS PAC ID: 7911816301 Enrollment ID: O20040120000329 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174888010 PECOS PAC ID: 2466353529 Enrollment ID: O20040204000304 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Albany Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710046461 PECOS PAC ID: 1850386616 Enrollment ID: O20040420000244 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Samaritan North Lincoln Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306897491 PECOS PAC ID: 7911816301 Enrollment ID: O20061104000117 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20061104000140 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Entity Name | Samaritan Pacific Health Services Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1801847066 PECOS PAC ID: 2466353529 Enrollment ID: O20061104000163 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Biegler, CRNA Po Box 3330, Salt Lake City, UT 84110-3330 Ph: () - | Ashley Biegler, CRNA 1046 6th Ave Sw, Albany, OR 97321-1916 Ph: (541) 812-4000 |
News Archive
All tissues, sick and healthy alike, need a blood supply to survive and grow. The key to many medical problems, like preventing tumour development, is therefore to obstruct the spread of the blood vessels. Research scientists at Karolinska Institutet have now discovered a heretofore unknown mechanism for how the body links together its blood vessels.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market - driven by the launch of several targeted agents over the next few years - will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Girindus, a leading service provider to the pharmaceutical industry and a dedicated manufacturer of therapeutic oligonucleotides, announces that Girindus Group is not affected by Solvay's decision to sell its Pharmaceuticals Sector to Abbott. Girindus is a member of Solvay Organics, which is part of the Chemicals Division of the Solvay Group and is therefore completely separate from the Pharmaceuticals Division.
The jama Pediatrics recently published new research on non-Hispanic black and white infants, the report analyzed the trends in overall and cause-specific infant mortality rates in the US population. According to a 2017 report from the US Centers for Disease Control and Prevention, US infant mortality rates in the past 10 years have decreased by 15%.
› Verified 3 days ago
Mr. Alexander Samuel Whidden, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 | |
Tyson Flohr, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 | |
Jaclyn Rochefort, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 | |
John Allen Oaks, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 | |
Lars Lunsmann, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 930 Sw 9th Avenue, Albany, OR 97321 Phone: 541-926-9611 Fax: 541-926-6152 | |
Michael E Emery, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-926-9611 | |
Jessica Rae Slaght-langworthy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 |